Suscripción a Biblioteca: Guest
Critical Reviews™ in Oncogenesis

Publicado 4 números por año

ISSN Imprimir: 0893-9675

ISSN En Línea: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

RKIP-Mediated Chemo-Immunosensitization of Resistant Cancer Cells via Disruption of the NF-κB/Snail/YY1/RKIP Resistance-Driver Loop

Volumen 19, Edición 6, 2014, pp. 431-445
DOI: 10.1615/CritRevOncog.2014011929
Get accessGet access

SINOPSIS

Cancer remains one of the most dreadful diseases. Whereas most treatment regimens for various cancers have resulted in improved clinical responses and sometimes cures, unfortunately, subsets of cancer patients are either pretreatment resistant or develop resistance following therapy. These subsets of patients develop cross-resistance to unrelated therapeutics and usually succumb to death. Thus, delineating the underlying molecular mechanisms of resistance of various cancers and identifying molecular targets for intervention are the current main focus of research investigations. One approach to investigate cancer resistance has been to identify pathways that regulate resistance and develop means to disrupt these pathways in order to override resistance and sensitize the resistant cells to cell death. Hence, we have identified one pathway that is dysregulated in cancer, namely, the NF-κB/Snail/YY1/RKIP loop, that has been shown to regulate, in large part, tumor cell resistance to apoptosis by chemotherapeutic and immunotherapeutic cytotoxic drugs. The dysregulated resistant loop is manifested by the overexpression of NF-κB, Snail, and YY1 activities and the underexpression of RKIP. The induction of RKIP expression results in the downregulation of NF-κB, Snail, and YY1 and the sensitization of resistant cells to drug-induced apoptosis. These findings identified RKIP, in addition to its antiproliferative and metastatic suppressor functions, as an anti-resistance factor. This brief review describes the role of RKIP in the regulation of drug sensitivity via disruption of the NF-κB/Snail/ YY1/RKIP loop that regulates resistance in cancer cells.

CITADO POR
  1. Vlahopoulos Spiros A., Cen Osman, Hengen Nina, Agan James, Moschovi Maria, Critselis Elena, Adamaki Maria, Bacopoulou Flora, Copland John A., Boldogh Istvan, Karin Michael, Chrousos George P., Dynamic aberrant NF-κB spurs tumorigenesis: A new model encompassing the microenvironment, Cytokine & Growth Factor Reviews, 26, 4, 2015. Crossref

  2. Ye Chunxiang, Shen Zhanlong, Wang Bo, Li Yansen, Li Tao, Yang Yang, Jiang Kewei, Ye Yingjiang, Wang Shan, A novel long non-coding RNA lnc-GNAT1-1 is low expressed in colorectal cancer and acts as a tumor suppressor through regulating RKIP-NF-κB-Snail circuit, Journal of Experimental & Clinical Cancer Research, 35, 1, 2016. Crossref

  3. Tsang Daisy PF, Wu William KK, Kang Wei, Lee Ying-Ying, Wu Feng, Yu Zhuo, Xiong Lei, Chan Anthony W, Tong Joanna H, Yang Weiqin, Li May SM, Lau Suki S, Li Xiangchun, Lee Sau-Dan, Yang Yihua, Lai Paul BS, Yu Dae-Yeul, Xu Gang, Lo Kwok-Wai, Chan Matthew TV, Wang Huating, Lee Tin L, Yu Jun, Wong Nathalie, Yip Kevin Y, To Ka-Fai, Cheng Alfred SL, Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma, The Journal of Pathology, 238, 5, 2016. Crossref

  4. Tilborghs Sam, Corthouts Jerome, Verhoeven Yannick, Arias David, Rolfo Christian, Trinh Xuan Bich, van Dam Peter A., The role of Nuclear Factor-kappa B signaling in human cervical cancer, Critical Reviews in Oncology/Hematology, 120, 2017. Crossref

  5. Bonavida B., Chouaib S., Resistance to anticancer immunity in cancer patients: potential strategies to reverse resistance, Annals of Oncology, 28, 3, 2017. Crossref

  6. Shvartsur Anna, Givechian Kevin B., Garban Hermes, Bonavida Benjamin, Overexpression of RKIP and its cross-talk with several regulatory gene products in multiple myeloma, Journal of Experimental & Clinical Cancer Research, 36, 1, 2017. Crossref

  7. Fouani Leyla, Kovacevic Zaklina, Richardson Des R., Targeting Oncogenic Nuclear Factor Kappa B Signaling with Redox-Active Agents for Cancer Treatment, Antioxidants & Redox Signaling, 30, 8, 2019. Crossref

  8. Zaravinos Apostolos, Bonavida Benjamin, Chatzaki Ekaterini, Baritaki Stavroula, RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact, Cancers, 10, 9, 2018. Crossref

  9. Wang Yu-Shi, Zhu Hongyan, Li He, Li Yang, Zhao Bing, Jin Ying-Hua, Ginsenoside compound K inhibits nuclear factor-kappa B by targeting Annexin A2, Journal of Ginseng Research, 43, 3, 2019. Crossref

  10. Wang Yuhao, Bonavida Benjamin, Pleiotropic activities of RKIP in cancer: Role in survival, EMT, chemo-immuno-resistance, and autophagy, in Prognostic and Therapeutic Applications of RKIP in Cancer, 2020. Crossref

  11. Noh Hae Sook, Hah Young-Sool, Ha Ji Hye, Kang Min Young, Zada Sahib, Rha Sun Young, Kang Sang Soo, Kim Hyun Joon, Park Jae-Yong, Byun June-Ho, Hahm Jong Ryeal, Shin Jeong Kyu, Jeong Sang-Ho, Lee Young-Joon, Kim Deok Ryong, Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity, Oncotarget, 7, 4, 2016. Crossref

  12. Yuan Li, Yi Hong-Mei, Yi Hong, Qu Jia-Quan, Zhu Jin-Feng, Li Li-Na, Xiao Ta, Zheng Zhen, Lu Shan-Shan, Xiao Zhi-Qiang, Reduced RKIP enhances nasopharyngeal carcinoma radioresistance by increasing ERK and AKT activity, Oncotarget, 7, 10, 2016. Crossref

  13. Dariya Begum, Chalikonda Gayathri, Alam Afroz, Nagaraju Ganji Purnachandra, Theranostic role of RKIP in cancer, in Prognostic and Therapeutic Applications of RKIP in Cancer, 2020. Crossref

  14. Cardoso-Carneiro Diana, Raquel-Cunha Ana, Pinheiro Joana, Gabriela-Freitas Maria, Fontão Patrícia, Reis Rui M., Martinho Olga, Implications of RKIP protein in cancer prognosis and therapy response: A literature update, in Prognostic and Therapeutic Applications of RKIP in Cancer, 2020. Crossref

  15. Özenver Nadire, Efferth Thomas, Therapeutic targeting of SNAIL, RKIP, and YY1 in tumor metastasis and drug resistance, in Prognostic and Therapeutic Applications of RKIP in Cancer, 2020. Crossref

  16. Ramos Alexandre Ferreira, dos Reis Gama Leonardo, de Morais Mauro César Cafundó, de Melo Martins Poliana Cristina, Stochastic modeling for investigation of the regulation of transcription of the RKIP gene, in Prognostic and Therapeutic Applications of RKIP in Cancer, 2020. Crossref

  17. Smeda Marta, Grosicki Marek, Chlopicki Stefan, Local and systemic endothelial cell response to cancer: RKIP-mimetic therapy and endothelial safety, in Prognostic and Therapeutic Applications of RKIP in Cancer, 2020. Crossref

  18. Wang Zhaoxia, Wang Honghong, Guo Hongrui, Li Fengyan, Wu Weiwei, Zhang Sanyuan, Wang Tong, The circadian rhythm and core gene Period2 regulate the chemotherapy effect and multidrug resistance of ovarian cancer through the PI3K signaling pathway, Bioscience Reports, 40, 11, 2020. Crossref

  19. Touboul Roni, Baritaki Stavroula, Zaravinos Apostolos, Bonavida Benjamin, RKIP Pleiotropic Activities in Cancer and Inflammatory Diseases: Role in Immunity, Cancers, 13, 24, 2021. Crossref

  20. Hu Chi-Tan, Mandal JayaPrakash, Wu Wen-Sheng, Regulation on tumor metastasis by Raf kinase inhibitory protein: New insight with reactive oxygen species signaling, Tzu Chi Medical Journal, 33, 4, 2021. Crossref

  21. Meng Zhi-jian, Tao Ke, Enhancement of Chemosensitivity by Stathmin-1 Silencing in Gastric Cancer Cells In Situ and In Vivo, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 23, 1, 2016. Crossref

  22. Navasardyan Inesa, Bonavida Benjamin, YY1 is involved in the pathogenesis and malignant properties of human triple-negative breast cancer (TNBC), in YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer, 2021. Crossref

  23. Giovanini Guilherme, Barros Luciana R. C., Gama Leonardo R., Tortelli Tharcisio C., Ramos Alexandre F., A Stochastic Binary Model for the Regulation of Gene Expression to Investigate Responses to Gene Therapy, Cancers, 14, 3, 2022. Crossref

  24. Vivarelli Silvia, Falzone Luca, Grillo Caterina Maria, Bonavida Benjamin, Crimi Claudia, La Mantia Ignazio, Libra Massimo, Computational Analyses of YY1 and Its Target RKIP Reveal Their Diagnostic and Prognostic Roles in Lung Cancer, Cancers, 14, 4, 2022. Crossref

  25. Cessna Hannah, Baritaki Stavroula, Zaravinos Apostolos, Bonavida Benjamin, The Role of RKIP in the Regulation of EMT in the Tumor Microenvironment, Cancers, 14, 19, 2022. Crossref

Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones Precios y Políticas de Suscripcione Begell House Contáctenos Language English 中文 Русский Português German French Spain